| Literature DB >> 36203875 |
Jiankang Zhang1, Xueping Xia1, Ying Zhu2, Zitong Lian1, Haifeng Tian1, Hanbing Xiao1, Qiaomu Hu1.
Abstract
Farmed chinese giant salamander (Andrias davidianus) was an important distinctive economically amphibian that exhibited male-biased sexual size dimorphism. Fgf9 and rspo1 genes antagonize each other in Wnt4 signal pathway to regulate mammalian gonadal differentiation has been demonstrated. However, their expression profile and function in A. davidianus are unclear. In this study, we firstly characterized fgf9 and rspo1 genes expression in developing gonad. Results showed that fgf9 expression level was higher in testes than in ovaries and increased from 1 to 6 years while rspo1 expression was higher in ovaries than in testes. In situ hybridization assay showed that both fgf9 and rspo1 genes expressed at 62 dpf in undifferentiated gonad, and fgf9 gene was mainly expressed in spermatogonia and sertoli cells in testis while strong positive signal of rspo1 was detected in granular cell in ovary. During sex-reversal, fgf9 expression was significantly higher in reversed testes and normal testes than in ovaries, and opposite expression pattern was detected for rspo1. When FH535 was used to inhibit Wnt/β-catenin pathway, expression of rspo1, wnt4 and β-catenin was down-regulated. Conversely, expression of fgf9, dmrt1, ftz-f1 and cyp17 were up-regulated. Furthermore, when rspo1 and fgf9 were knocked down using RNAi technology, respectively. We observed that female biased genes were down regulated in ovary primordial cells after rspo1 was knocked down, while the opposite expression profile was observed in testis primordial cells after fgf9 was knocked down. These results suggested that fgf9 and rspo1 played an antagonistic role to regulate sex differentiation in the process of the gonadal development and provided a foundation for further functional characterizations. The data also provided basic information for genome editing breeding to improve the Chinese giant salamander farming industry.Entities:
Keywords: Andrias davidianus; FGF9; antagonize; rspo1; sex differentiation
Year: 2022 PMID: 36203875 PMCID: PMC9530786 DOI: 10.3389/fmolb.2022.974348
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
Primers and sequences used in this study.
| Primers | Primer sequences (5′-3′) | Utilizations |
|---|---|---|
| UPM-long | CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT | 5′or 3′RACE |
| UPM-short | CTAATACGACTCACTATAGGGC | 5′or 3′RACE |
|
| GGCCCAGGTGCTCGCTCAACAACATCG | 5′ region clone |
|
| AGGGCATCCTAAGGCGCAGGCAGCTCT | 3′region clone |
|
| GGAACACTTCAGGCACCCGTTGGACT | 5′ region clone |
|
| TCCGAGTCCAACGGGTGCCTGAAGT | 3′region clone |
|
| TTAACGGCCCTAACACCAGG | Sex identification |
|
| GGTTTAGGGCGGCTCTGATT | Sex identification |
|
| TTGGCAGCATCCTCGTTTG | qRT-PCR |
|
| CAGGTGCTCGCTCAACAACAT | qRT-PCR |
|
| GTCCAACGGGTGCCTGAAG | qRT-PCR |
|
| ATTGCGAACGCCGAAGTATC | qRT-PCR |
| fzd2-A | TGCGATGGGTTGGCAGTAG | qRT-PCR |
| fzd2-S | CTGAGGGAGCAAAGAGGGC | qRT-PCR |
| Wnt4-A | CTCGGGTCCCTTGCGTTAC | qRT-PCR |
| Wnt4-S | CGGTGGGCAGCATTTCAG | qRT-PCR |
| β-catenin-A | GCACAGGTTACAACATTGATGTCAT | qRT-PCR |
| β-catenin-S | CAAACCTGCGATTGTTGAAGC | qRT-PCR |
|
| GGTTATGCCCTGCCTCACG | Internal control |
|
| ATTTCCCTTTCGGCTGTGG | Internal control |
|
| GGTGGAAAGCCCGATGTTG |
|
|
| ATCACTAATACGACTCACTATAGTGATGCCACTTAGTCCTAGTCCCT |
|
|
| GATCACTAATACGACTCACTATAGGGTGGAAAGCCCGATGTTG |
|
|
| TGATGCCACTTAGTCCTAGTCCCT |
|
|
| TCCTGAGCTTCATGGATGTAGC |
|
|
| GATCACTAATACGACTCACTATAGCGTCGTGTCTCCCGAAGGT |
|
|
| GATCACTAATACGACTCACTATAGTCCTGAGCTTCATGGATGTAGC |
|
|
| CGTCGTGTCTCCCGAAGGT |
|
| ad | GCACCCGGCAAGAUCACAATT | Sence |
| ad | UUGUGAUCUUGCCGGGUGCTT | Antisence |
| ad | GCGUAGACAGUGGACUCUATT | Sence |
| ad | UAGAGUCCACUGUCUACGCTT | Antisence |
| ad | GCGAUAUUAUGUGGCUCUATT | Sence |
| ad | UAGAGCCACAUAAUAUCGCTT | Antisence |
| ad | GCAAAGGGUUGUGACUCUUTT | Sence |
| ad | AAGAGUCACAACCCUUUGCTT | Antisence |
| ad | GCGUUCGCAAUCCAGACAUTT | Sence |
| ad | AUGUCUGGAUUGCGAACGCTT | Antisence |
| ad | GCAAAGAAGGCUUGUACUUTT | Sence |
| ad | AAGUACAAGCCUUCUUUGCTT | Antisence |
| Negative control (NC) | UUCUCCGAACGUGUCACGUTT | Sence |
| Negative control (NC) | ACGUGACACGUUCGGAGAATT | Antisence |
FIGURE 1Expression of fgf9 and rspo1 gene: expression analysis of fgf9 (A) and rspo1 (B) in various tissues by qRT-PCR; expression analysis of fgf9 (C) and rspo1 (D) in developing gonads by qRT-PCR. Tissue from three individuals and each reaction was repeated three times. Bars with different letters are significantly different (p < 0.05). Li, Liver; Br, Brain; Pi, pituitary; Lu:Lung; Ov, Ovary; Te, Testis; St, Stomach; In, Intestinal; Ki, Kidney; Sp, Spleen.
FIGURE 2Expression of fgf9 (A) and rspo1 (B) in gonads detected by in situ hybridization. 1. Undifferentiated gonad at 62dpf; 2. Large magnification of frame area in (1); 3. Differentiating gonad at 98 dpf; 4. Large magnification of frame area in (3); 5. Differentiating gonad at 130dpf; 6. Large magnification of frame area in (5); 7: 2 year old ovary; 8. Large magnification of frame area in (7); 9. 2 year old testis; 10. Large magnification of frame area in (9). 62dpf: gonad at 62 days after fertilization; 98dpf: gonad at 98 days after fertilization; 2 YF: 2-year-old female gonad;2 YM: 2-year-old male gonad. Three samples were used per stage. Germ cell (GC), granulosa cells (GrC), sertoli cell (SeC), spermatogonia (SpG), spermatocyte (SpT).
FIGURE 3Expression of fgf9 and rspo1 in normal gonads and sex-reversal gonads by qRT-PCR. (A) Expression analysis of fgf9 mRNA in normal gonads and sex-reversal gonads by qRT-PCR; (B) expression analysis of rspo1 mRNA in normal gonads and sex-reversal gonads by qRT-PCR. The gonads were collected at 1 year old from three individuals and each reaction was repeated three times. Bars with different letters are significantly different (p < 0.05).
FIGURE 4Expression profile of sex-related genes after FH535 treatment. The results from three replicates and *indicate the significantly difference (p < 0.05).
FIGURE 5Expression profiles of sex-related gene in Andrias davidianus gonad after siRNA treatment. (A) control siRNA marked by FAM transfected into the gonadal cells; (B) Expression level of each rspo1 siRNA sites in ovary cell; (C) expression profile of sex-related genes after R684 treatment in ovary cell; (D) expression level of each fgf9 siRNA sites in testis cell; (E) expression profile of sex-related genes after F890 treatment in testis cell; (F) expression profile of sex-related genes after R684 treatment in ovary tissue; (G) expression profile of sex-related genes after F890 treatment in testis tissue. The results from three replicates and *indicate the significantly difference (p < 0.05).